Malaria Vaccine

Antimalaria toxin vaccine prevents severe adverse effects and death in mice

Published in TB and Outbreaks Week, October 29th, 2002

by Maria G. Essig, MS, ELS, senior medical writer - A vaccine targeted at a purported malaria toxin, glycosylphosphatidylinositol, protected mice against the severe effects of malaria infection, including death, according to a report in Nature.

"The malaria parasite Plasmodium falciparum infects 5-10% of the world's population and kills 2 million people annually," reported Louis Schofield and colleagues at the Royal Melbourne Hospital in Australia and the Massachusetts Institute of Technology in the United States. "Fatalities are thought to result in part from pathological reactions initiated by a malarial toxin."

Schofield and his...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of TB and Outbreaks Week

Source: TB and Outbreaks Week (2002-10-29)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry